ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India End Stage Renal Disease Treatment Market Report & Forecast 2023-2029
Published Date: December 2023
|
Report Code: QYRE-Auto-35I16026
Home | Market Reports | Health| Health Conditions
Global and India End Stage Renal Disease Treatment Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India End Stage Renal Disease Treatment Market Report & Forecast 2023-2029

Code: QYRE-Auto-35I16026
Report
December 2023
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
NIKKISO
Wego
Newsol
Mayo Clinic
Guangdong Biolight
Medtronic Inc
Sanxin Medtec
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical

and India End Stage Renal Disease Treatment Market Size

The global End Stage Renal Disease Treatment revenue was US$ 55330 million in 2022 and is forecast to a readjusted size of US$ 76120 million by 2029 with a CAGR of 5.5% during the review period (2023-2029).

and India End Stage Renal Disease Treatment Market

and India End Stage Renal Disease Treatment Market

End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive.
In India, the End Stage Renal Disease Treatment revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2023-2029.
Fresenius is one of the most important global key players of the end stage renal disease treatment, holds about 20% of shares of the global end stage renal disease treatment market, other key players include DaVita, Baxter, etc. North America is the largest market, occupied for about 40 percent, followed by the Asia Pacific. In terms of type, hemodialysis is the largest segment, with a share of about 70%, and in terms of application, the kidney dialysis centers segment holds a share of over 60 percent.
This report focuses on global and India End Stage Renal Disease Treatment market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for End Stage Renal Disease Treatment will continue to grow rapidly in the future.
Global End Stage Renal Disease Treatment Scope and Market Size
End Stage Renal Disease Treatment market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global End Stage Renal Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For India market, this report focuses on the End Stage Renal Disease Treatment market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India End Stage Renal Disease Treatment Market Report

Report Metric Details
Report Name and India End Stage Renal Disease Treatment Market
Forecasted market size in 2029 US$ 76120 million
CAGR 5.5%
Forecasted years 2023 - 2029
Segment by Type
  • Hemodialysis
  • Peritoneal Dialysis
  • Kidney Transplantation
Segment by Application
  • Hospitals
  • Kidney Dialysis Centers
  • At Homes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Fresenius, DaVita, Baxter, Nipro, B. Braun, Asahi Kasei, Nikkiso, WEGO, Newsol, Mayo Clinic, Guangdong Biolight, Medtronic, Sanxin Medtec, Jafron Biomedical, SWS Hemodialysis Care, Tianyi Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India End Stage Renal Disease Treatment Market size in 2029?

Ans: The and India End Stage Renal Disease Treatment Market size in 2029 will be US$ 76120 million.

What is the Fresenius, DaVita, Baxter share in and India End Stage Renal Disease Treatment Market?

Ans: Fresenius is one of the most important global key players of the end stage renal disease treatment, holds about 20% of shares of the global end stage renal disease treatment market, other key players include DaVita, Baxter, etc.

What is the and India End Stage Renal Disease Treatment Market share by type?

Ans: In terms of type, hemodialysis is the largest segment, with a share of about 70%, and in terms of application, the kidney dialysis centers segment holds a share of over 60 percent.

What is the and India End Stage Renal Disease Treatment Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India End Stage Renal Disease Treatment Market report?

Ans: The main players in the and India End Stage Renal Disease Treatment Market are Fresenius, DaVita, Baxter, Nipro, B. Braun, Asahi Kasei, Nikkiso, WEGO, Newsol, Mayo Clinic, Guangdong Biolight, Medtronic, Sanxin Medtec, Jafron Biomedical, SWS Hemodialysis Care, Tianyi Medical

What are the Application segmentation covered in the and India End Stage Renal Disease Treatment Market report?

Ans: The Applications covered in the and India End Stage Renal Disease Treatment Market report are Hospitals, Kidney Dialysis Centers, At Homes, Others

What are the Type segmentation covered in the and India End Stage Renal Disease Treatment Market report?

Ans: The Types covered in the and India End Stage Renal Disease Treatment Market report are Hemodialysis, Peritoneal Dialysis, Kidney Transplantation

1 Study Coverage
1.1 End Stage Renal Disease Treatment Product Introduction
1.2 Global End Stage Renal Disease Treatment Outlook 2018 VS 2022 VS 2029
1.2.1 Global End Stage Renal Disease Treatment Market Size for the Year 2018-2029
1.2.2 India End Stage Renal Disease Treatment Market Size for the Year 2018-2029
1.3 End Stage Renal Disease Treatment Market Size, India VS Global, 2018 VS 2022 VS 2029
1.3.1 The Market Share of India End Stage Renal Disease Treatment in Global, 2018 VS 2022 VS 2029
1.3.2 The Growth Rate of End Stage Renal Disease Treatment Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4 End Stage Renal Disease Treatment Market Dynamics
1.4.1 End Stage Renal Disease Treatment Industry Trends
1.4.2 End Stage Renal Disease Treatment Market Drivers
1.4.3 End Stage Renal Disease Treatment Market Challenges
1.4.4 End Stage Renal Disease Treatment Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 End Stage Renal Disease Treatment by Type
2.1 End Stage Renal Disease Treatment Market Segment by Type
2.1.1 Hemodialysis
2.1.2 Peritoneal Dialysis
2.1.3 Kidney Transplantation
2.2 Global End Stage Renal Disease Treatment Market Size by Type (2018, 2022 & 2029)
2.3 Global End Stage Renal Disease Treatment Market Size by Type (2018-2029)
2.4 India End Stage Renal Disease Treatment Market Size by Type (2018, 2022 & 2029)
2.5 India End Stage Renal Disease Treatment Market Size by Type (2018-2029)
3 End Stage Renal Disease Treatment by Application
3.1 End Stage Renal Disease Treatment Market Segment by Application
3.1.1 Hospitals
3.1.2 Kidney Dialysis Centers
3.1.3 At Homes
3.1.4 Others
3.2 Global End Stage Renal Disease Treatment Market Size by Application (2018, 2022 & 2029)
3.3 Global End Stage Renal Disease Treatment Market Size by Application (2018-2029)
3.4 India End Stage Renal Disease Treatment Market Size by Application (2018, 2022 & 2029)
3.5 India End Stage Renal Disease Treatment Market Size by Application (2018-2029)
4 Global End Stage Renal Disease Treatment Competitor Landscape by Company
4.1 Global End Stage Renal Disease Treatment Market Size by Company
4.1.1 Global Key Companies of End Stage Renal Disease Treatment, Ranked by Revenue (2022)
4.1.2 Global End Stage Renal Disease Treatment Revenue by Player (2018-2023)
4.2 Global End Stage Renal Disease Treatment Concentration Ratio (CR)
4.2.1 End Stage Renal Disease Treatment Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of End Stage Renal Disease Treatment in 2022
4.2.3 Global End Stage Renal Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of End Stage Renal Disease Treatment Head office and Area Served
4.4 Global Key Players of End Stage Renal Disease Treatment, Product and Application
4.5 Global Key Players of End Stage Renal Disease Treatment, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India End Stage Renal Disease Treatment Market Size by Company
4.7.1 Key Players of End Stage Renal Disease Treatment in India, Ranked by Revenue (2022)
4.7.2 India End Stage Renal Disease Treatment Revenue by Players (2021, 2022 & 2023)
5 Global End Stage Renal Disease Treatment Market Size by Region
5.1 Global End Stage Renal Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global End Stage Renal Disease Treatment Market Size by Region (2018-2029)
5.2.1 Global End Stage Renal Disease Treatment Market Size by Region: 2018-2023
5.2.2 Global End Stage Renal Disease Treatment Market Size by Region (2024-2029)
6 Americas
6.1 Americas End Stage Renal Disease Treatment Market Size YoY Growth 2018-2029
6.2 Americas End Stage Renal Disease Treatment Market Size by Type
6.2.1 Americas End Stage Renal Disease Treatment Market Size by Type (2018-2023)
6.2.2 Americas End Stage Renal Disease Treatment Market Size by Type (2024-2029)
6.2.3 Americas End Stage Renal Disease Treatment Market Share by Type (2018-2029)
6.3 Americas End Stage Renal Disease Treatment Market Size by Application
6.3.1 Americas End Stage Renal Disease Treatment Market Size by Application (2018-2023)
6.3.2 Americas End Stage Renal Disease Treatment Market Size by Application (2024-2029)
6.3.3 Americas End Stage Renal Disease Treatment Market Share by Application (2018-2029)
6.4 Americas End Stage Renal Disease Treatment Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA End Stage Renal Disease Treatment Market Size YoY Growth 2018-2029
7.2 EMEA End Stage Renal Disease Treatment Market Size by Type
7.2.1 EMEA End Stage Renal Disease Treatment Market Size by Type (2018-2023)
7.2.2 EMEA End Stage Renal Disease Treatment Market Size by Type (2024-2029)
7.2.3 EMEA End Stage Renal Disease Treatment Market Share by Type (2018-2029)
7.3 EMEA End Stage Renal Disease Treatment Market Size by Application
7.3.1 EMEA End Stage Renal Disease Treatment Market Size by Application (2018-2023)
7.3.2 EMEA End Stage Renal Disease Treatment Market Size by Application (2024-2029)
7.3.3 EMEA End Stage Renal Disease Treatment Market Share by Application (2018-2029)
7.4 EMEA End Stage Renal Disease Treatment Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China End Stage Renal Disease Treatment Market Size YoY Growth 2018-2029
8.2 China End Stage Renal Disease Treatment Market Size by Type
8.2.1 China End Stage Renal Disease Treatment Market Size by Type (2018-2023)
8.2.2 China End Stage Renal Disease Treatment Market Size by Type (2024-2029)
8.2.3 China End Stage Renal Disease Treatment Market Share by Type (2018-2029)
8.3 China End Stage Renal Disease Treatment Market Size by Application
8.3.1 China End Stage Renal Disease Treatment Market Size by Application (2018-2023)
8.3.2 China End Stage Renal Disease Treatment Market Size by Application (2024-2029)
8.3.3 China End Stage Renal Disease Treatment Market Share by Application (2018-2029)
9 APAC (excluding China)
9.1 APAC End Stage Renal Disease Treatment Market Size YoY Growth 2018-2029
9.2 APAC End Stage Renal Disease Treatment Market Size by Type
9.2.1 APAC End Stage Renal Disease Treatment Market Size by Type (2018-2023)
9.2.2 APAC End Stage Renal Disease Treatment Market Size by Type (2024-2029)
9.2.3 APAC End Stage Renal Disease Treatment Market Share by Type (2018-2029)
9.3 APAC End Stage Renal Disease Treatment Market Size by Application
9.3.1 APAC End Stage Renal Disease Treatment Market Size by Application (2018-2023)
9.3.2 APAC End Stage Renal Disease Treatment Market Size by Application (2024-2029)
9.3.3 APAC End Stage Renal Disease Treatment Market Share by Application (2018-2029)
9.4 APAC End Stage Renal Disease Treatment Market Facts & Figures by Country (2018, 2022 & 2029)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Fresenius
10.1.1 Fresenius Company Details
10.1.2 Fresenius Business Overview
10.1.3 Fresenius End Stage Renal Disease Treatment Introduction
10.1.4 Fresenius Revenue in End Stage Renal Disease Treatment Business (2018-2023)
10.1.5 Fresenius Recent Development
10.2 DaVita
10.2.1 DaVita Company Details
10.2.2 DaVita Business Overview
10.2.3 DaVita End Stage Renal Disease Treatment Introduction
10.2.4 DaVita Revenue in End Stage Renal Disease Treatment Business (2018-2023)
10.2.5 DaVita Recent Development
10.3 Baxter
10.3.1 Baxter Company Details
10.3.2 Baxter Business Overview
10.3.3 Baxter End Stage Renal Disease Treatment Introduction
10.3.4 Baxter Revenue in End Stage Renal Disease Treatment Business (2018-2023)
10.3.5 Baxter Recent Development
10.4 Nipro
10.4.1 Nipro Company Details
10.4.2 Nipro Business Overview
10.4.3 Nipro End Stage Renal Disease Treatment Introduction
10.4.4 Nipro Revenue in End Stage Renal Disease Treatment Business (2018-2023)
10.4.5 Nipro Recent Development
10.5 B. Braun
10.5.1 B. Braun Company Details
10.5.2 B. Braun Business Overview
10.5.3 B. Braun End Stage Renal Disease Treatment Introduction
10.5.4 B. Braun Revenue in End Stage Renal Disease Treatment Business (2018-2023)
10.5.5 B. Braun Recent Development
10.6 Asahi Kasei
10.6.1 Asahi Kasei Company Details
10.6.2 Asahi Kasei Business Overview
10.6.3 Asahi Kasei End Stage Renal Disease Treatment Introduction
10.6.4 Asahi Kasei Revenue in End Stage Renal Disease Treatment Business (2018-2023)
10.6.5 Asahi Kasei Recent Development
10.7 Nikkiso
10.7.1 Nikkiso Company Details
10.7.2 Nikkiso Business Overview
10.7.3 Nikkiso End Stage Renal Disease Treatment Introduction
10.7.4 Nikkiso Revenue in End Stage Renal Disease Treatment Business (2018-2023)
10.7.5 Nikkiso Recent Development
10.8 WEGO
10.8.1 WEGO Company Details
10.8.2 WEGO Business Overview
10.8.3 WEGO End Stage Renal Disease Treatment Introduction
10.8.4 WEGO Revenue in End Stage Renal Disease Treatment Business (2018-2023)
10.8.5 WEGO Recent Development
10.9 Newsol
10.9.1 Newsol Company Details
10.9.2 Newsol Business Overview
10.9.3 Newsol End Stage Renal Disease Treatment Introduction
10.9.4 Newsol Revenue in End Stage Renal Disease Treatment Business (2018-2023)
10.9.5 Newsol Recent Development
10.10 Mayo Clinic
10.10.1 Mayo Clinic Company Details
10.10.2 Mayo Clinic Business Overview
10.10.3 Mayo Clinic End Stage Renal Disease Treatment Introduction
10.10.4 Mayo Clinic Revenue in End Stage Renal Disease Treatment Business (2018-2023)
10.10.5 Mayo Clinic Recent Development
10.11 Guangdong Biolight
10.11.1 Guangdong Biolight Company Details
10.11.2 Guangdong Biolight Business Overview
10.11.3 Guangdong Biolight End Stage Renal Disease Treatment Introduction
10.11.4 Guangdong Biolight Revenue in End Stage Renal Disease Treatment Business (2018-2023)
10.11.5 Guangdong Biolight Recent Development
10.12 Medtronic
10.12.1 Medtronic Company Details
10.12.2 Medtronic Business Overview
10.12.3 Medtronic End Stage Renal Disease Treatment Introduction
10.12.4 Medtronic Revenue in End Stage Renal Disease Treatment Business (2018-2023)
10.12.5 Medtronic Recent Development
10.13 Sanxin Medtec
10.13.1 Sanxin Medtec Company Details
10.13.2 Sanxin Medtec Business Overview
10.13.3 Sanxin Medtec End Stage Renal Disease Treatment Introduction
10.13.4 Sanxin Medtec Revenue in End Stage Renal Disease Treatment Business (2018-2023)
10.13.5 Sanxin Medtec Recent Development
10.14 Jafron Biomedical
10.14.1 Jafron Biomedical Company Details
10.14.2 Jafron Biomedical Business Overview
10.14.3 Jafron Biomedical End Stage Renal Disease Treatment Introduction
10.14.4 Jafron Biomedical Revenue in End Stage Renal Disease Treatment Business (2018-2023)
10.14.5 Jafron Biomedical Recent Development
10.15 SWS Hemodialysis Care
10.15.1 SWS Hemodialysis Care Company Details
10.15.2 SWS Hemodialysis Care Business Overview
10.15.3 SWS Hemodialysis Care End Stage Renal Disease Treatment Introduction
10.15.4 SWS Hemodialysis Care Revenue in End Stage Renal Disease Treatment Business (2018-2023)
10.15.5 SWS Hemodialysis Care Recent Development
10.16 Tianyi Medical
10.16.1 Tianyi Medical Company Details
10.16.2 Tianyi Medical Business Overview
10.16.3 Tianyi Medical End Stage Renal Disease Treatment Introduction
10.16.4 Tianyi Medical Revenue in End Stage Renal Disease Treatment Business (2018-2023)
10.16.5 Tianyi Medical Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
FEATURED COMPANIES
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
NIKKISO
Wego
Newsol
Mayo Clinic
Guangdong Biolight
Medtronic Inc
Sanxin Medtec
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical
List of Tables
    Table 1. End Stage Renal Disease Treatment Market Size India VS Global, CAGR (2018 VS 2022 VS 2029)
    Table 2. End Stage Renal Disease Treatment Market Trends
    Table 3. End Stage Renal Disease Treatment Market Drivers
    Table 4. End Stage Renal Disease Treatment Market Challenges
    Table 5. End Stage Renal Disease Treatment Market Restraints
    Table 6. Global End Stage Renal Disease Treatment Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India End Stage Renal Disease Treatment Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global End Stage Renal Disease Treatment Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India End Stage Renal Disease Treatment Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Companies of End Stage Renal Disease Treatment, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global End Stage Renal Disease Treatment Revenue by Player, (US$ Million), 2018-2023
    Table 12. Global End Stage Renal Disease Treatment Revenue Share by Player, 2018-2023
    Table 13. Global End Stage Renal Disease Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global End Stage Renal Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End Stage Renal Disease Treatment as of 2022)
    Table 15. Global Key Players of End Stage Renal Disease Treatment, Headquarters and Area Served
    Table 16. Global Key Players of End Stage Renal Disease Treatment, Product and Application
    Table 17. Global Key Players of End Stage Renal Disease Treatment, Date of Enter into This Industry
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Key Players of End Stage Renal Disease Treatment in India, Ranked by Revenue (2022) & (US$ Million)
    Table 20. India End Stage Renal Disease Treatment Revenue by Players, (US$ Million), 2021, 2022 & 2023
    Table 21. India End Stage Renal Disease Treatment Revenue Share by Players, 2021, 2022 & 2023
    Table 22. Global End Stage Renal Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 23. Global End Stage Renal Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 24. Global End Stage Renal Disease Treatment Market Size Forecast by Region (2024-2029) & (US$ Million)
    Table 25. Americas End Stage Renal Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Americas End Stage Renal Disease Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Americas End Stage Renal Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Americas End Stage Renal Disease Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 29. Americas End Stage Renal Disease Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 30. Americas End Stage Renal Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 31. Americas End Stage Renal Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 32. EMEA End Stage Renal Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 33. EMEA End Stage Renal Disease Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 34. EMEA End Stage Renal Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 35. EMEA End Stage Renal Disease Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 36. EMEA End Stage Renal Disease Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. EMEA End Stage Renal Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 38. EMEA End Stage Renal Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 39. China End Stage Renal Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 40. China End Stage Renal Disease Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 41. China End Stage Renal Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 42. China End Stage Renal Disease Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 43. China End Stage Renal Disease Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. APAC End Stage Renal Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 45. APAC End Stage Renal Disease Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 46. APAC End Stage Renal Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 47. APAC End Stage Renal Disease Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 48. APAC End Stage Renal Disease Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 49. APAC End Stage Renal Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 50. APAC End Stage Renal Disease Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 51. Fresenius Company Details
    Table 52. Fresenius Business Overview
    Table 53. Fresenius End Stage Renal Disease Treatment Product
    Table 54. Fresenius Revenue in End Stage Renal Disease Treatment Business (2018-2023) & (US$ Million)
    Table 55. Fresenius Recent Development
    Table 56. DaVita Company Details
    Table 57. DaVita Business Overview
    Table 58. DaVita End Stage Renal Disease Treatment Product
    Table 59. DaVita Revenue in End Stage Renal Disease Treatment Business (2018-2023) & (US$ Million)
    Table 60. DaVita Recent Development
    Table 61. Baxter Company Details
    Table 62. Baxter Business Overview
    Table 63. Baxter End Stage Renal Disease Treatment Product
    Table 64. Baxter Revenue in End Stage Renal Disease Treatment Business (2018-2023) & (US$ Million)
    Table 65. Baxter Recent Development
    Table 66. Nipro Company Details
    Table 67. Nipro Business Overview
    Table 68. Nipro End Stage Renal Disease Treatment Product
    Table 69. Nipro Revenue in End Stage Renal Disease Treatment Business (2018-2023) & (US$ Million)
    Table 70. Nipro Recent Development
    Table 71. B. Braun Company Details
    Table 72. B. Braun Business Overview
    Table 73. B. Braun End Stage Renal Disease Treatment Product
    Table 74. B. Braun Revenue in End Stage Renal Disease Treatment Business (2018-2023) & (US$ Million)
    Table 75. B. Braun Recent Development
    Table 76. Asahi Kasei Company Details
    Table 77. Asahi Kasei Business Overview
    Table 78. Asahi Kasei End Stage Renal Disease Treatment Product
    Table 79. Asahi Kasei Revenue in End Stage Renal Disease Treatment Business (2018-2023) & (US$ Million)
    Table 80. Asahi Kasei Recent Development
    Table 81. Nikkiso Company Details
    Table 82. Nikkiso Business Overview
    Table 83. Nikkiso End Stage Renal Disease Treatment Product
    Table 84. Nikkiso Revenue in End Stage Renal Disease Treatment Business (2018-2023) & (US$ Million)
    Table 85. Nikkiso Recent Development
    Table 86. WEGO Company Details
    Table 87. WEGO Business Overview
    Table 88. WEGO End Stage Renal Disease Treatment Product
    Table 89. WEGO Revenue in End Stage Renal Disease Treatment Business (2018-2023) & (US$ Million)
    Table 90. WEGO Recent Development
    Table 91. Newsol Company Details
    Table 92. Newsol Business Overview
    Table 93. Newsol End Stage Renal Disease Treatment Product
    Table 94. Newsol Revenue in End Stage Renal Disease Treatment Business (2018-2023) & (US$ Million)
    Table 95. Newsol Recent Development
    Table 96. Mayo Clinic Company Details
    Table 97. Mayo Clinic Business Overview
    Table 98. Mayo Clinic End Stage Renal Disease Treatment Product
    Table 99. Mayo Clinic Revenue in End Stage Renal Disease Treatment Business (2018-2023) & (US$ Million)
    Table 100. Mayo Clinic Recent Development
    Table 101. Guangdong Biolight Company Details
    Table 102. Guangdong Biolight Business Overview
    Table 103. Guangdong Biolight End Stage Renal Disease Treatment Product
    Table 104. Guangdong Biolight Revenue in End Stage Renal Disease Treatment Business (2018-2023) & (US$ Million)
    Table 105. Guangdong Biolight Recent Development
    Table 106. Medtronic Company Details
    Table 107. Medtronic Business Overview
    Table 108. Medtronic End Stage Renal Disease Treatment Product
    Table 109. Medtronic Revenue in End Stage Renal Disease Treatment Business (2018-2023) & (US$ Million)
    Table 110. Medtronic Recent Development
    Table 111. Sanxin Medtec Company Details
    Table 112. Sanxin Medtec Business Overview
    Table 113. Sanxin Medtec End Stage Renal Disease Treatment Product
    Table 114. Sanxin Medtec Revenue in End Stage Renal Disease Treatment Business (2018-2023) & (US$ Million)
    Table 115. Sanxin Medtec Recent Development
    Table 116. Jafron Biomedical Company Details
    Table 117. Jafron Biomedical Business Overview
    Table 118. Jafron Biomedical End Stage Renal Disease Treatment Product
    Table 119. Jafron Biomedical Revenue in End Stage Renal Disease Treatment Business (2018-2023) & (US$ Million)
    Table 120. Jafron Biomedical Recent Development
    Table 121. SWS Hemodialysis Care Company Details
    Table 122. SWS Hemodialysis Care Business Overview
    Table 123. SWS Hemodialysis Care End Stage Renal Disease Treatment Product
    Table 124. SWS Hemodialysis Care Revenue in End Stage Renal Disease Treatment Business (2018-2023) & (US$ Million)
    Table 125. SWS Hemodialysis Care Recent Development
    Table 126. Tianyi Medical Company Details
    Table 127. Tianyi Medical Business Overview
    Table 128. Tianyi Medical End Stage Renal Disease Treatment Product
    Table 129. Tianyi Medical Revenue in End Stage Renal Disease Treatment Business (2018-2023) & (US$ Million)
    Table 130. Tianyi Medical Recent Development
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. End Stage Renal Disease Treatment Product Picture
    Figure 2. Global End Stage Renal Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global End Stage Renal Disease Treatment Market Size 2018-2029 (US$ Million)
    Figure 4. India End Stage Renal Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 5. India End Stage Renal Disease Treatment Market Size 2018-2029 (US$ Million)
    Figure 6. India End Stage Renal Disease Treatment Market Share in Global 2018-2029
    Figure 7. End Stage Renal Disease Treatment Report Years Considered
    Figure 8. Product Picture of Hemodialysis
    Figure 9. Product Picture of Peritoneal Dialysis
    Figure 10. Product Picture of Kidney Transplantation
    Figure 11. Global End Stage Renal Disease Treatment Market Share by Type in 2022 & 2029
    Figure 12. Global End Stage Renal Disease Treatment Market Size by Type (2018-2029) & (US$ Million)
    Figure 13. Global End Stage Renal Disease Treatment Market Share by Type (2018-2029)
    Figure 14. India End Stage Renal Disease Treatment Market Share by Type in 2022 & 2029
    Figure 15. India End Stage Renal Disease Treatment Market Size by Type (2018-2029) & (US$ Million)
    Figure 16. India End Stage Renal Disease Treatment Market Share by Type (2018-2029)
    Figure 17. Product Picture of Hospitals
    Figure 18. Product Picture of Kidney Dialysis Centers
    Figure 19. Product Picture of At Homes
    Figure 20. Product Picture of Others
    Figure 21. Global End Stage Renal Disease Treatment Market Share by Application in 2022 & 2029
    Figure 22. Global End Stage Renal Disease Treatment Market Size by Application (2018-2029) & (US$ Million)
    Figure 23. Global End Stage Renal Disease Treatment Market Share by Application (2018-2029)
    Figure 24. India End Stage Renal Disease Treatment Market Share by Application in 2022 & 2029
    Figure 25. India End Stage Renal Disease Treatment Market Size by Application (2018-2029) & (US$ Million)
    Figure 26. India End Stage Renal Disease Treatment Market Share by Application (2018-2029)
    Figure 27. The Top 5 and 10 Largest Companies of End Stage Renal Disease Treatment in the World: Market Share by End Stage Renal Disease Treatment Revenue in 2022
    Figure 28. Global End Stage Renal Disease Treatment Market Size Market Share by Region: 2018 VS 2022 VS 2029
    Figure 29. Global End Stage Renal Disease Treatment Market Share by Region (2018-2029)
    Figure 30. Americas End Stage Renal Disease Treatment Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 31. Americas End Stage Renal Disease Treatment Market Share by Type (2018-2029)
    Figure 32. Americas End Stage Renal Disease Treatment Market Share by Application (2018-2029)
    Figure 33. United States End Stage Renal Disease Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Canada End Stage Renal Disease Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Mexico End Stage Renal Disease Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Brazil End Stage Renal Disease Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 37. EMEA End Stage Renal Disease Treatment Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 38. EMEA End Stage Renal Disease Treatment Market Share by Type (2018-2029)
    Figure 39. EMEA End Stage Renal Disease Treatment Market Share by Application (2018-2029)
    Figure 40. Europe End Stage Renal Disease Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Middle East End Stage Renal Disease Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Africa End Stage Renal Disease Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 43. China End Stage Renal Disease Treatment Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 44. China End Stage Renal Disease Treatment Market Share by Type (2018-2029)
    Figure 45. China End Stage Renal Disease Treatment Market Share by Application (2018-2029)
    Figure 46. APAC End Stage Renal Disease Treatment Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 47. APAC End Stage Renal Disease Treatment Market Share by Type (2018-2029)
    Figure 48. APAC End Stage Renal Disease Treatment Market Share by Application (2018-2029)
    Figure 49. Japan End Stage Renal Disease Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 50. South Korea End Stage Renal Disease Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 51. China Taiwan End Stage Renal Disease Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Southeast Asia End Stage Renal Disease Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 53. India End Stage Renal Disease Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Fresenius Revenue Growth Rate in End Stage Renal Disease Treatment Business (2018-2023)
    Figure 55. DaVita Revenue Growth Rate in End Stage Renal Disease Treatment Business (2018-2023)
    Figure 56. Baxter Revenue Growth Rate in End Stage Renal Disease Treatment Business (2018-2023)
    Figure 57. Nipro Revenue Growth Rate in End Stage Renal Disease Treatment Business (2018-2023)
    Figure 58. B. Braun Revenue Growth Rate in End Stage Renal Disease Treatment Business (2018-2023)
    Figure 59. Asahi Kasei Revenue Growth Rate in End Stage Renal Disease Treatment Business (2018-2023)
    Figure 60. Nikkiso Revenue Growth Rate in End Stage Renal Disease Treatment Business (2018-2023)
    Figure 61. WEGO Revenue Growth Rate in End Stage Renal Disease Treatment Business (2018-2023)
    Figure 62. Newsol Revenue Growth Rate in End Stage Renal Disease Treatment Business (2018-2023)
    Figure 63. Mayo Clinic Revenue Growth Rate in End Stage Renal Disease Treatment Business (2018-2023)
    Figure 64. Guangdong Biolight Revenue Growth Rate in End Stage Renal Disease Treatment Business (2018-2023)
    Figure 65. Medtronic Revenue Growth Rate in End Stage Renal Disease Treatment Business (2018-2023)
    Figure 66. Sanxin Medtec Revenue Growth Rate in End Stage Renal Disease Treatment Business (2018-2023)
    Figure 67. Jafron Biomedical Revenue Growth Rate in End Stage Renal Disease Treatment Business (2018-2023)
    Figure 68. SWS Hemodialysis Care Revenue Growth Rate in End Stage Renal Disease Treatment Business (2018-2023)
    Figure 69. Tianyi Medical Revenue Growth Rate in End Stage Renal Disease Treatment Business (2018-2023)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20V18395
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32G20014
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions